Tirzepatide trials for Crohn's disease

All Tirzepatide trials · All Crohn's disease trials

Phase breakdown

Recruiting trials studying Tirzepatide for Crohn's disease

• Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
  NCT06774079 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
  NCT06937099 · Phase: Phase 3 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 183 locations
• Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
  NCT06976853 · Phase: Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 3 locations

Common questions

How many trials study Tirzepatide for Crohn's disease?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.